secwatch / observer
8-K filed April 3, 2023, 7:59 PM ET ticker RNXT CIK 0001574094
other material confidence high sentiment neutral materiality 0.70

RenovoRx raises $5M in registered direct offering and private placement of common stock and warrants

RenovoRx, Inc.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

RenovoRx, Inc. entered into Securities Purchase Agreement with a certain institutional investor valued at approximately $5.00 million (effective 2023-03-30).

Action
entry
Agreement
equity purchase
Counterparty
a certain institutional investor
Value
approximately $5.00 million
Effective
2023-03-30
Exact text from the filing
On March 30, 2023, RenovoRx, Inc. (the “ Company ,” “ we ” or “ us ”) entered into a securities purchase agreement (“ Securities Purchase Agreement ”) with a certain institutional investor (“ Purchaser ”).
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

RenovoRx, Inc. entered into Placement Agreement with Roth Capital Partners, LLC (effective 2023-03-30).

Action
entry
Agreement
underwriting
Counterparty
Roth Capital Partners, LLC
Effective
2023-03-30
Exact text from the filing
Roth Capital Partners, LLC (the “ Placement Agent ”) acted as the exclusive placement agent for the Offerings, pursuant to a placement agency agreement (the “ Placement Agreement ”), dated March 30, 2023, by and between the Company and the Placement Agent.
View on SEC.gov

Browse all material agreements →

RenovoRx, Inc. filing history →

Source: SEC EDGAR
accession 0001493152-23-010652
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.